ACTR-51. REMARKABLE RESPONSE OF A PATIENT WITH SECONDARY GBM TO A HISTONE DEACETYLASE INHIBITOR

Glioblastomas are highly aggressive, grade IV tumors of glial cells that arise either as de novo primary tumors or as secondary tumors, which malignantly transformed from lower grade gliomas. Secondary glioblastomas have a relatively low incidence making up 5–10% of all glioblastoma diagnoses and te...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Shu, Hui-Kuo, Gurbani, Saumya, Ramesh, Karthik, Weinberg, Brent, Voloschin, Alfredo, Olson, Jeffrey, Shim, Hyunsuk
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Adult Clinical Trials - Non-Immunologic
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846946/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.093
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы